{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:58:36Z","timestamp":1776898716238,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98322","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:57:29Z","timestamp":1764694649000},"source":"Crossref","is-referenced-by-count":0,"title":["Netherton Syndrome: A Systematic Review of the Challenges of Diagnosis and Treatment"],"prefix":"10.7759","author":[{"given":"Maximus S","family":"Reese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Haynos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanu","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Speer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000536083","article-title":"Netherton syndrome with a novel likely pathogenic variant c. 420del (p. Ser141ProfsTer5) in SPINK5 gene: a case report","volume":"16","author":"Kovacheva K","year":"2024","unstructured":"Kovacheva K, Kamburova Z, Vasilev P, Yordanova I. Netherton syndrome with a novel likely pathogenic variant c. 420del (p. Ser141ProfsTer5) in SPINK5 gene: a case report. Case Rep Dermatol. 2024, 16:47. 10.1159\/000536083","journal-title":"Case Rep Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/genes14051080","article-title":"Netherton syndrome caused by heterozygous frameshift mutation combined with homozygous c. 1258A> G  polymorphism in SPINK5 gene","volume":"14","author":"Moltrasio C","year":"2023","unstructured":"Moltrasio C, Romagnuolo M, Riva D, et al.. Netherton syndrome caused by heterozygous frameshift mutation combined with homozygous c. 1258A> G  polymorphism in SPINK5 gene. Genes. 2023, 14:1080. 10.3390\/genes14051080","journal-title":"Genes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.943264","article-title":"A novel mutation in SPINK5 gene underlies a case of atypical Netherton syndrome","volume":"13","author":"Wang Y","year":"2022","unstructured":"Wang Y, Song H, Yu L, Wu N, Zheng X, Liang B, Wang P. A novel mutation in SPINK5 gene underlies a case of atypical Netherton syndrome. Front Genet. 2022, 13:943264. 10.3389\/fgene.2022.943264","journal-title":"Front Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776983","article-title":"Severe hypernatremia as presentation of Netherton syndrome","volume":"10","author":"Di Nora A","year":"2023","unstructured":"Di Nora A, Consentino MC, Messina G, Timpanaro T, Smilari P, Pavone P. Severe hypernatremia as presentation of Netherton syndrome. Glob Med Genet. 2023, 10:335-8. 10.1055\/s-0043-1776983","journal-title":"Glob Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243260","article-title":"Netherton syndrome associated to Candida parapsilosis otomycosis","volume":"14","author":"Merad Y","year":"2021","unstructured":"Merad Y, Derrar H, Ouldsaid K, Benallel K. Netherton syndrome associated to Candida parapsilosis otomycosis. BMJ Case Rep. 2021, 14:e243260. 10.1136\/bcr-2021-243260","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2010.51.6.808","article-title":"Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis","volume":"51","author":"Lee SE","year":"2010","unstructured":"Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J. 2010, 51:808-22. 10.3349\/ymj.2010.51.6.808","journal-title":"Yonsei Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14939","article-title":"A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata","volume":"39","author":"Gordon H","year":"2022","unstructured":"Gordon H, Yap P, Hsiao KC, Watson M, Purvis D. A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata. Pediatr Dermatol. 2022, 39:268-72. 10.1111\/pde.14939","journal-title":"Pediatr Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56439","article-title":"Two incidental sibling diagnoses of Netherton syndrome in separate visits: a case report","volume":"16","author":"AlMoosawi S","year":"2024","unstructured":"AlMoosawi S, Alkhanaizi S, Albaharna M, Khamdan F. Two incidental sibling diagnoses of Netherton syndrome in separate visits: a case report. Cureus. 2024, 16:e56439. 10.7759\/cureus.56439","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.4.2021.047","article-title":"A novel SPINK5 gene mutation associated with Netherton syndrome in an Omani patient","volume":"21","author":"Hamza N","year":"2021","unstructured":"Hamza N, Al Sukaiti N, Ahmed KA, Romano R, Gokhale UA, Pan-Hammarstr\u00f6m Q. A novel SPINK5 gene mutation associated with Netherton syndrome in an Omani patient. Sultan Qaboos Univ Med J. 2021, 21:652. 10.18295\/squmj.4.2021.047","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5108","article-title":"Netherton syndrome plus atopic dermatitis: two new genetic mutations in the same patient","volume":"9","author":"Moar A","year":"2021","unstructured":"Moar A, Bruni M, Schena D, et al.. Netherton syndrome plus atopic dermatitis: two new genetic mutations in the same patient. Clin Case Rep. 2021, 9:e05108. 10.1002\/ccr3.5108","journal-title":"Clin Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55905","article-title":"Interprofessional collaboration: differentiating Netherton syndrome and atopic dermatitis in an African American infant","volume":"16","author":"Park EG","year":"2024","unstructured":"Park EG, Besly K, Campos JJ, Rezk A. Interprofessional collaboration: differentiating Netherton syndrome and atopic dermatitis in an African American infant. Cureus. 2024, 16:e55905. 10.7759\/cureus.55905","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9166","article-title":"A case report on Netherton syndrome","volume":"12","author":"Abdalrheem WO","year":"2020","unstructured":"Abdalrheem WO, Alluhayyan OB, Alharbi A. A case report on Netherton syndrome. Cureus. 2020, 12:e9166. 10.7759\/cureus.9166","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.12.013","article-title":"Vulvovaginal involvement in Netherton syndrome: a case report","volume":"45","author":"Bertrand C","year":"2024","unstructured":"Bertrand C, Funaro D. Vulvovaginal involvement in Netherton syndrome: a case report. JAAD Case Rep. 2024, 45:4-6. 10.1016\/j.jdcr.2023.12.013","journal-title":"JAAD Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8770","article-title":"Netherton syndrome-a therapeutic challenge in childhood","volume":"12","author":"Kostova P","year":"2024","unstructured":"Kostova P, Petrova G, Shahid M, et al.. Netherton syndrome-a therapeutic challenge in childhood. Clin Case Rep. 2024, 12:e8770. 10.1002\/ccr3.8770","journal-title":"Clin Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.62718","article-title":"Netherton syndrome in Thai children: a report of two cases with a literature review","volume":"16","author":"Temboonnark P","year":"2024","unstructured":"Temboonnark P, Daengsuwan T. Netherton syndrome in Thai children: a report of two cases with a literature review. Cureus. 2024, 16:e62718. 10.7759\/cureus.62718","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1611","article-title":"A novel SPINK5 donor splice site variant in a child with Netherton syndrome","volume":"9","author":"Mintoff D","year":"2021","unstructured":"Mintoff D, Borg I, Vornweg J, et al.. A novel SPINK5 donor splice site variant in a child with Netherton syndrome. Mol Genet Genomic Med. 2021, 9:e1611. 10.1002\/mgg3.1611","journal-title":"Mol Genet Genomic Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/dermatopathology11030024","article-title":"Interleukin-36 is highly expressed in skin biopsies from two patients with Netherton syndrome","volume":"11","author":"Pawlowski J","year":"2024","unstructured":"Pawlowski J, Pukhalskaya T, Cordoro K, Ibraheim MK, North JP. Interleukin-36 is highly expressed in skin biopsies from two patients with Netherton syndrome. Dermatopathology (Basel). 2024, 11:230-7. 10.3390\/dermatopathology11030024","journal-title":"Dermatopathology (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1297658","article-title":"Case report: Interleukin-17 targeted biological therapy in Netherton syndrome","volume":"11","author":"Mahajan R","year":"2023","unstructured":"Mahajan R, Bakshi S, Kumar A, De D, Handa S. Case report: Interleukin-17 targeted biological therapy in Netherton syndrome. Front Pediatr. 2023, 11:1297658. 10.3389\/fped.2023.1297658","journal-title":"Front Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1600","article-title":"Netherton syndrome caused by compound heterozygous mutation, c. 80A> G mutation in SPINK5 and large\u2010sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin","volume":"9","author":"Zhang Z","year":"2021","unstructured":"Zhang Z, Pan C, Wei R, et al.. Netherton syndrome caused by compound heterozygous mutation, c. 80A> G mutation in SPINK5 and large\u2010sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin. Mol Genet Genomic Med. 2021, 9:e1600. 10.1002\/mgg3.1600","journal-title":"Mol Genet Genomic Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14318","article-title":"A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome","volume":"37","author":"Zelieskova M","year":"2020","unstructured":"Zelieskova M, Banovcin P, Kozar M, Kozarova A, Nudzajova Z, Jesenak M. A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome. Pediatr Dermatol. 2020, 37:1202-4. 10.1111\/pde.14318","journal-title":"Pediatr Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/children 9030310","article-title":"Dupilumab improves pruritus in Netherton syndrome: a case study","volume":"9","author":"Inaba Y","year":"2022","unstructured":"Inaba Y, Kanazawa N, Muraoka K, et al.. Dupilumab improves pruritus in Netherton syndrome: a case study. Children. 2022, 9:310. 10.3390\/children 9030310","journal-title":"Children"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01837-z","article-title":"Dupilumab in a 9-week-old with Netherton syndrome leads to deep symptom control","volume":"45","author":"Vollmuth Y","year":"2024","unstructured":"Vollmuth Y, Alelq NA, Sattler F, Schmidt S, Hauck F. Dupilumab in a 9-week-old with Netherton syndrome leads to deep symptom control. J Clin Immunol. 2024, 45:42. 10.1007\/s10875-024-01837-z","journal-title":"J Clin Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2025.100508","article-title":"Successful management of Netherton syndrome using IVIG and dupilumab: a case report","volume":"4","author":"Johar R","year":"2025","unstructured":"Johar R, Khojah A, Goronfolah L. Successful management of Netherton syndrome using IVIG and dupilumab: a case report. J Allergy Clin Immunol Glob. 2025, 4:100508. 10.1016\/j.jacig.2025.100508","journal-title":"J Allergy Clin Immunol Glob"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.04.025","article-title":"Successful use of secukinumab in Netherton syndrome","volume":"6","author":"Blanchard SK","year":"2020","unstructured":"Blanchard SK, Prose NS. Successful use of secukinumab in Netherton syndrome. JAAD Case Rep. 2020, 6:577-8. 10.1016\/j.jdcr.2020.04.025","journal-title":"JAAD Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.946411","article-title":"Secukinumab as a novel treatment for chronic Netherton syndrome in a young adult","volume":"26","author":"Buchukuri I","year":"2025","unstructured":"Buchukuri I, Chalatashvili G, Gotua M, Robakidze K, Khutsishvili N, Lortkipanidze N. Secukinumab as a novel treatment for chronic Netherton syndrome in a young adult. Am J Case Rep. 2025, 26:e946411. 10.12659\/AJCR.946411","journal-title":"Am J Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2025.1667357","article-title":"Clinical characteristics of Netherton syndrome and exploration of targeted biologic therapy: two case reports","volume":"6","author":"Xiang W","year":"2025","unstructured":"Xiang W, Lian C, Lu J, Zheng W, Li Q. Clinical characteristics of Netherton syndrome and exploration of targeted biologic therapy: two case reports. Front Allergy. 2025, 6:1667357. 10.3389\/falgy.2025.1667357","journal-title":"Front Allergy"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2447883","article-title":"Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated","volume":"36","author":"Tang JT","year":"2025","unstructured":"Tang JT, Qin YL, Zhao WJ, Tu Y, Sun DJ. Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated. J Dermatolog Treat. 2025, 36:2447883. 10.1080\/09546634.2024.2447883","journal-title":"J Dermatolog Treat"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39349","article-title":"Oral tofacitinib therapy for the effective management of Netherton syndrome","volume":"15","author":"Dodeja A","year":"2023","unstructured":"Dodeja A, Meshram K, Pande S, Oke M, Borkar M. Oral tofacitinib therapy for the effective management of Netherton syndrome. Cureus. 2023, 15:e39349. 10.7759\/cureus.39349","journal-title":"Cureus"},{"key":"ref29","article-title":"Treatment of Netherton syndrome in pediatrics with upadacitinib","volume":"31","author":"Sun C","year":"2025","unstructured":"Sun C, Chen Y. Treatment of Netherton syndrome in pediatrics with upadacitinib. Altern Ther Health Med. 2025, 31:266-9.","journal-title":"Altern Ther Health Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14590","article-title":"Infliximab therapy in an infant with Netherton syndrome","volume":"38","author":"Cicek F","year":"2021","unstructured":"Cicek F, Cekic S, Kilic SS. Infliximab therapy in an infant with Netherton syndrome. Pediatr Dermatol. 2021, 38:714-6. 10.1111\/pde.14590","journal-title":"Pediatr Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104323","article-title":"Significant response to Pembrolizumab for metastatic cutaneous squamous cell carcinoma in patient with Netherton syndrome","volume":"81","author":"Tos SM","year":"2022","unstructured":"Tos SM, Alqam BN, Giacaman N, Ibdah MG, Gabajah MM, Altell A. Significant response to Pembrolizumab for metastatic cutaneous squamous cell carcinoma in patient with Netherton syndrome. Ann Med Surg (Lond). 2022, 81:e104323. 10.1016\/j.amsu.2022.104323","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420532-netherton-syndrome-a-systematic-review-of-the-challenges-of-diagnosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:57:29Z","timestamp":1764694649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420532-netherton-syndrome-a-systematic-review-of-the-challenges-of-diagnosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.98322","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}